Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease

An 8-Week Randomized Double Blind Placebo Controlled Multicenter Trial to Evaluate the Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease.

The purpose of this study is to determine whether treatment with 40mg of Rosuvastatin for 8 weeks will reduce the number of episodes of myocardial ischaemia suffered in subjects with coronary artery disease.

Inclusion Criteria:

• Evidence of Coronary arterial disease
• Suffering ischaemic episodes/exercise induced ischaemia
• Not taking any cholesterol lowering medication

Exclusion Criteria:

• Unstable angina or heart attack less than one month before trial entry
• Coronary arterial surgery as defined by protocol
• Uncontrolled hypertension, diabetes, hypothyroidism or laboratory values as defined by the protocol.